Erythrocyte-Mediated Drug Delivery for the Prevention of Stent Restenosis (Q61918551)
Jump to navigation
Jump to search
clinical trial
Language | Label | Description | Also known as |
---|---|---|---|
English | Erythrocyte-Mediated Drug Delivery for the Prevention of Stent Restenosis |
clinical trial |
Statements
TROY (English)
0 references
Erythrocyte-Mediated Drug Delivery for the Prevention of Restenosis After Coronary Artery Stent Implantation:TROY-Study (English)
0 references
July 2007
0 references
100
0 references
20 year
0 references